KALA BIO, Inc. (KALA)
Builds AI software that helps biotech companies analyze research and drug trial data.
$0.66-0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-99.8%
The outlook
KALA is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling a sustained downtrend. Analyst coverage appears minimal based on available data. The overall sentiment leans bearish given the stock's depressed positioning and technical weakness.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$12.3M
52-wk high
$1,030.00
52-wk low
$0.59
50-day avg
$2.03
200-day avg
$20.48
Trailing P/E
—